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Statistical methods have been reviewed recently (Ghosh
and Schork, 1996; Lander and Kruglyak, 1995; LanderThe destruction or disruption of the body's own tissues
and Schork, 1994; Thomson, 1995; Weeks and Lathrop,by the immune system results from a complex interac-
1995), as has the topic of genetic predisposition to auto-tion of genetic and environmental factors. Inbred popu-
immunity (Theofilopoulos, 1995). We will, therefore, re-lations such as laboratory strains of mice and rats and
view recent results briefly, but focus on the implicationsoutbred populations such as humans harbor a pool of
and interpretation of current data.DNA mutations or allelic variants that affect the expres-
sion/function of genes involved in control of the immune
response. Individually, most mutations in the genome Animal Models of Autoimmunity
Some of thebest-studied animal models of spontaneoushave mild, if not undetectable, effects, but in combina-
tion with ªnormalº alleles of other loci produce a measur- and induced autoimmune disease have now been sub-
jected to genome scans: the nonobese diabetic mouseable and occasionally lethal autoimmune phenotype.
Many of these mutations may be normal variants, which (NOD; insulin-dependent diabetes [Idd] loci) (Wicker et
al., 1995); the F1 hybrid of New Zealand black (NZB)in other circumstances act to maintain the health of the
individual. They may have subtle quantitative effects, and New Zealand white (NZW) mice (Theofilopoulos,
1995) and the MRL-lpr mouse (Watson et al., 1992),bestowing a relatively small risk of disease. We refer
to primary, predisposing allelic variants as ªetiological which develop a disease similar to human systemic lu-
pus erythematosus (SLE; Sle or Lbw [lupus±NZB 3mutationsº to distinguish them from other polymor-
phisms that play no direct role in disease. It is empha- NZW] loci) (Kono et al., 1994; Kotzin, 1996 [this issue of
Cell]); experimental allergic encephalomyelitis (EAE; eaesized that the term mutation is used here generically
and is not meant to infer function. The incomplete risk loci), a model of multiple sclerosis (Steinman, 1996 [this
issue of Cell]); experimental allergic orchitis (EAO; Orchconferred by any single allele makes both the mapping
and final identification of these etiological mutations loci; anti-testis autoimmunity) (Meeker et al., 1995); and
autoimmune ovarian dysgenesis (AOD; Aod loci) (War-difficult. This single characteristic is the main reason
why most common diseases such as autoimmune con- dell et al., 1995), in which neonatal mice are thymecto-
mized at 3 days of age (Figure 1). Mice are the model ofditions are not inherited in a simple Mendelian way, but
instead have a complex or unknown mode of inheri- choice for mammalian genetic analysis (Frankel, 1995).
Moreover, the environment is controlled and is not atance. Identification of these etiological mutations and
an understanding of their functional consequences will variable in the cumulative frequency of disease in the
cross. Therefore, the reduction of disease frequencyimpact the diagnosis, treatment, and prevention of auto-
immune diseases, which affect about 4% of the popula- from the susceptible parental strain to that observed in
the cross-progeny is solely a reflection of the genestion (see Table 1).
segregating in the cross, their penetrances (the proba-
bility that an etiological mutation can cause the disease),Genetic Analysis on a Whole-Genome Scale
and how the products of these genes relate.The availability of easy to use maps of markers that
cover the entire mouse (and rat) and human genomes
(Dietrich et al., 1994; Gyapay et al., 1994) has enabled Chromosome Mapping Genes in Mice
The first step is to ascertain the cumulative diseasethe chromosome localization of almost 40 genes that
predispose to autoimmunity in animal models and in frequency in the parental strains, the F1 hybrids, the
first backcross generation, which is the progeny of anhuman disease (Figure 1). Human studies are in their
infancy, but genome-wide linkage studies are underway F1 3 parent mating, and the (F1 3 F1)F2 generation.
Marker allele frequencies are determined in either back-for most of the diseases listed in Table 1. The markers
are simple tandem repeats or microsatellites, which oc- cross progeny or F2 progeny, or preferably both (Mc-
Aleer et al., 1995), in as many affected and unaffectedcur in mammalian genomes at fairly even intervals of
about 105 bp. Microsatellite markers possess high levels progeny as possible; they will vary in disease progeny
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Figure 1. Chromosome Locations of Mouse Genes Associated with Autoimmune Disease
We have positioned 38 murine disease loci (horizontal bars) according to the marker locus most linked to the trait from genome scanning
experiments. Where appropriate, 6 5 cM confidence intervals are indicated with vertical bars. Loci colored red are linked to type 1 diabetes,
those colored purple to SLE or SLE-associated autoantibody production (or both), those colored blue to EAE, those colored pink to EAO,
and those colored green to AOD.
There are currently 13 separate type 1 diabetes non-MHC loci mapped (Idd2 through Idd15; Chesnut et al., 1993; de Gouyon et al., 1993;
Ghosh et al., 1993; McAleer et al., 1995; Morahan et al., 1994; Serreze et al., 1994; Wicker et al., 1995) (Idd8 and Idd11 are probably the same
locus). Nine separate loci (excluding lpr/Fas and gld/Fas ligand; Nagata and Suda, 1995) have been linked to SLE or to SLE-associated
autoantibody production (or both) (Sle1±Sle3 [Morel et al., 1994], Lbw2, Lbw3, and Lbw5±Lbw7 [Kono et al., 1994], and nba1 [Drake et al.,
1994]; it is probable that Sle1 is equivalent to Lbw7 and Sle3 is equivalent to Lbw5), five in EAE (eae) (Baker et al., 1995; Sundvall et al., 1995),
three in EAO (Orch3, Orch4, and Orch5; Meeker et al., 1995), and two in AOD (Aod1 and Aod2; Teuscher et al., 1996; Wardell et al., 1995).
Loci such as Lbw4 and Lbw8 (Kono et al., 1994), which had statistical support of p > 0.003, were not included. The loci eae4 (chromosome
7), eae5 (chromosome 11), and eae6 (chromosome 18) are named here for convenience; although linkage data were reported by Baker et al.
(1995) with support at p < 0.003, the possibility of segregation distortion was not eliminated. Map distances are based on the version 3.1 of
the Mouse Genome Database, which contains additional information and references for all loci. Additional genes shown are as follows: Il1r1
and Il1r2 (interleukin-1 receptor 1 and 2), Ctla4, Cd28, Bcl2, Nramp1 (natural resistance±associated macrophage protein), and Lshs (unofficial
nomenclature) on chromosome 11, which controls T cell responsiveness to interleukin-12 and susceptibility to Leishmania infection (Guler et
al., 1996). Periinsulitis, sialitis, hyperimmunoglobulin production, and resistance of T cells to apoptosis in NOD mice have been mapped to
the Bcl2 locus, named here as Nod1 (Garchon et al., 1994). Nod1 overlaps with the SLE-associated Sbw1 locus (splenomegaly) (Kono et al.,
1994), which affects lymphoid hyperplasia and hypereactivity. Sbw2 on chromosome 4 (Kono et al., 1994) is probably the same as Sle2 (Morel
et al., 1994). Interleukin-1 receptor antagonist (Il1rn) on chromosome 2 has been associated with, but not linked to, a number of human
autoimmune diseases (Blakemore et al., 1995). The Idd13 locus maps to the interleukin-1 gene on chromosome 2 (Serreze et al., 1994). Il2
(interleukin-2) maps to the 4 cM congenic interval of Idd3 (Lord et al., 1995), overlapping with Aod2 (Teuscher et al., 1996). Aia1 is a locus
controlling autoimmune hemolytic anemia on chromosome 4 that overlaps with the Idd9 and nba1 loci. The D6Nds1/Idd locus was detected
in a NOD 3 Mus spretus backcross and maps close to Igk (immunoglobulin light chain locus) (de Gouyon et al., 1993) and Tcrb (T cell receptor
b-chain). The D6Mit52/Idd linkage was observed in a cross of NOD with NON (McAleer et al., 1995) and might be distinct from Idd6. Nod3
signifies a locus linked to dexamethazone resistance/apoptosis of NOD T cells and colocalizes with Idd6 (Penha-Goncalves et al., 1995). Idd7
and Sle, a locus linked in the MRL-lpr mouse, colocalize at the centromere of chromosome 7 with the candidate gene Tgfb1 (Watson et al.,
1992). Nod2 is a subphenotype of NOD involving a T cell proliferative defect mapping to the marker D11Mit38, which is in a cluster of
immunomodulatory genes, the b-chemokines (Gill et al., 1995). Igh is the immunoglobulin heavy chain locus on chromosome 12. H2 is the
MHC on chromosome 17. Mbp is the myelin basic protein gene on chromosome 18 and does not overlap with eae6 (Baker et al., 1995). Note
that the Sle1 10 cM interval overlaps with Fasl (Morel et al., 1994). Bphs is the Bordetella pertussis±induced histamine sensitization locus,
involved in both EAO and EAE susceptibility (Sudweeks et al., 1993).
For the published human IDDM2±IDDM5, IDDM7, and IDDM8 loci on chromosomes 11p15 (Bennett et al., 1995), 15q26 (Field et al., 1994),
11q13 (Davies et al., 1994; Hashimoto et al., 1994), 6q25 (Davies et al., 1994), 2q31 (Copeman et al., 1995; Owerbach and Gabbay, 1995), and
6q27 (Luo et al., 1995),respectively, the nearest genes that have been mapped in both mouse and humans were selected and placed in the
figure according to the position of the mouse gene, e.g., the human thrombospondin gene is in the vicinity of IDDM8 on chromosome 6q27,
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Table 1. Population Frequencies and Familial Clustering of published data on non-MHC loci accrued from mouse
Human Autoimmune and Immune-Related Diseases genome scan studies of NOD type 1 diabetes, EAE, EAO,
AOD, and the New Zealand and MRL models of SLE. InPopulation Sibling
Frequency Risk addition, all of the models require a gene or genes in
Disease (%) (%) ls MHC ls the MHC on chromosome 17.
The composite map shows that the intervals for genesPsoriasisa 2.8 17 6 ND
Rheumatoid arthritisb 1.0 8 8 1.6 for different diseases overlap. If each disease locus is
Graves' disease 0.5 7.5 15 ND considered to be positioned accurately within a 10 cM
Type 1 diabetesc 0.4 6 15 2.4 interval, then three of nine SLE loci colocalize with an
Ankylosing spondilitisd 0.13 7 54 4.2
Idd locus interval. This is unlikely to have occurred byMultiple sclerosisc 0.1 2 20 2.4
chance (binomial p 5 0.02). Moreover, two of three OrchUlcerative colitise 0.1 1.2 12 8.3
(EAO) loci colocalize with Idd loci (p 5 0.02). It seemsLupus (SLE)f 0.1 2 20 ND
Crohn's diseasee 0.06 1.2 20 1.3 likely, therefore, that the observed clustering of disease
Narcolepsyg 0.06 1 12 ND genes is not random. These data suggest that mutations
Celiac diseasec 0.05 3 60 5.2 exist that cause general defects in immune regulation
Primary biliary cirrhosish 0.008 0.8 100 ND
(such as the polarization of T cells into Th1 and Th2
Population prevalences and sibling risk values are averaged values phenotypes; Charlton and Lafferty, 1995; Tisch and
from a wide literature studying different ethnic groups. The values McDevitt, 1996 [this issue of Cell]) or apoptosis (Garchon
have wide confidence intervals, as have the ls values. ls 5 sibling et al., 1994; Nagata and Suda, 1995; Penha-Goncalves
risk/population sibling risk prevalence. ND, not determined.
et al., 1995), while other genes that are unique to aa Elder et al., 1994
disease determine the susceptibility of the target organb Wordsworth, 1995
c Risch, 1987 to autoimmune response (Sudweeks et al., 1993), such
d Brown and Wordsworth, 1996 as the expression of an organ-specific antigen and its
e Satsangi et al., 1996 specific interaction with the class II and class I mole-
f Hochberg, 1987 cules of the MHC (Wicker et al., 1995). Note that in Figureg Guilleminault et al., 1989
1 several loci are shown that are linked to autoimmuneh Gregory and Bassendine, 1994
disease±associated phenotypes such as apoptosis
(Nod3 on chromosome 6) (Penha-Goncalves et al.,
1995), T cell and B cell activity (Nod1, Sbw1 and Sbw2,
from the expected Mendelian ratios (1:1 for a backcross and Nod2 on chromosomes 1, 4, and 11; Garchon et
and 1:2:1 for an intercross) if a marker locus is near a al., 1994; Gill et al., 1995; Kono et al., 1994), and suscepti-
disease locus. Cross-progeny without disease are es- bility to infectious diseases (Nramp1 [Vidal et al., 1995]
sential controls, and it is also important to establish and Lshs [Guler et al., 1996] on chromosomes 1 and
that the marker allele frequencies in all progeny (or a 11), which may influence autoimmunity via dysregulation
randomly selected subset) do not vary from the Mende- of the immune system, e.g., by perturbing the Th1/Th2
lian ratios. Sample sizes are absolutely critical for the balance.
reliability of genome scan results. Small sample sizes,
say less than 50 mice, will have a high false-positive
rate, where false-positive results are simply random Modes of Inheritance
fluctuations. False-positive results can be reduced or Key information can be obtained about the relation be-
made highly unlikely by replicating the results in more tween the action of disease gene products and the num-
than one cross and by taking a low probability (p) value ber and effect of loci linked to the disease observed in
as a statistical threshold for significance. In murine auto- the genome scan by analysis of the frequency of disease
immune disease models, p < 0.001 has been taken as in the parental strains and the F1, BC1, and F2 progeny.
sufficient evidence to name a locus in a genome scan Only 13% of progeny of a (NOD 3 C57BL/10.H2g7) 3
and undertake more experiments to confirm it. For ex- NOD backcross developed diabetes, which is much less
ample, of 13 separate non±major histocompatibility than the 45% frequency expected if a single, fully reces-
complex (MHC) Idd loci named, there is additional, inde- sive-acting gene was segregating and 7-fold less than
pendent support for 12 of them (Idd15 has not yet been the 90% frequency observed in parental female NOD
tested; Figure 1). Nevertheless, even more stringent mice. If such a locus existed, it would have a genotypic
statistical criteria have been suggested (Lander and risk ratio (GRR) (the total number of affected progeny/
Kruglyak, 1995). two times the number of homozygous affected progeny)
of 0.5, i.e., all affected progeny would have the NOD
Map Positions homozygous genotype at the disease locus (Risch et
In themselves, map positions are important because al., 1993). Hence, there must be more than one gene
they suggest candidate genes already mapped to the segregating. Genome scanning revealed that Idd2
disease gene interval. Figure 1 summarizes currently through Idd10 were segregating, but these genes still did
not account for the 7-fold decrease in disease frequency
from NOD parental mice to backcross progeny. The
GRRs for these nine Idd loci were, respectively, 0.84,
and the mouse Thbs2 maps to mouse chromosome 17. These as-
0.51 (Idd3 and Idd10 are combined because they aresignments are very approximate, and when the IDDM loci are identi-
linked on chromosome 3), 0.72, 0.85, 0.77, 1.47, 1.67,fied and their homologs are mapped they may be different than
proposed. and 0.72. Note that none of the loci is fully recessive
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with a GRR of 0.5 and that the GRRs of Idd7 and Idd8 of the donor strain to the recipient (Frankel, 1995). Thus,
it is possible to compare two strains of mice differingexceed 1.0, indicative of genes in which the susceptibil-
ity is contributed from the resistant strain. only for a specific chromosome segment. The construc-
tion of congenic strains has proved that chromosomeTwo main genetic models were fitted to the backcross
data: the multiplicative model, which is a special model 3 has two separate but linked Idd loci (Wicker et al.,
1994), Idd3 and Idd10, that interact in synergistic wayof epistasis with simple mathematical properties (rela-
tive penetrances are multiplied) and is approximately (Wicker et al., 1994) and has narrowed the Idd3-con-
taining region down to 4 cM (Lord et al., 1995). Congenicequivalent to the classic polygenic threshold liability
model (in the liability model, the data from the measured strains for the MHC have proved invaluable in sorting
out the relative contributions of MHC-linked genes andphenotypes are transformed into a logarithmic or logistic
scale so that they can be added together); and, second, non-MHC-linked genes (Ikegami et al., 1995; Wicker et
al., 1995). Once it is established that the specific regionthe heterogeneity model, in which genes act indepen-
dently of each other and can substitute for each other contains a disease gene, the gene can be mapped to
0.1 cM by developing further congenic strains.(Risch et al., 1993). Epistasis or gene interaction implies
that the disease gene products interact, in contrast with
heterogeneity, in which the defective proteins are caus-
Human Autoimmune Diseaseing etiologically distinct forms of the disease. At the
Clustering of disease in families is caused by environ-outset, the heterogeneity model could be rejected be-
mental factors, genetic factors, or both. The degree ofcause the frequency of disease in the backcross prog-
clustering of disease in families can be estimated fromeny was less than 45%. Statistically, the multiplicative
the ratio of the risk for siblings of patients with a diseasemodel fit the data better than the heterogeneity model.
and the population prevalence of that disease (Risch,Nevertheless, when the GRRs for all nine of the detected
1987) (Table 1). If this ratio, ls, is close to 1.0, then thereloci were multiplied together, the overall product was
is no evidence for familial clustering. Note, however, for0.36, which is greater than the experimental value of
the 12 diseases listed in Table 1, the ls value greatly0.14 (calculated by dividing the proportion of mice with
exceeds 1.0, ranging from 6±100. For example, if a familydiabetes in the backcross progeny [0.13] by the propor-
has a child with type 1 diabetes, then the other siblingstion of parental NOD mice that develop diabetes [0.9]).
are at a 15 times greater risk of developing diabetesTherefore, there must be a large number of additional
than a member of the general population. It cannot begenes with small, undetectable effects segregating in
assumed that genes are fully responsible, because envi-the cross (Risch et al., 1993). Similar conclusions have
ronmental factors can also cause familial clustering.been reached in plant genetics, in which relatively few
However, it has recently been shown for multiple sclero-genes account for the bulk of variation in many popula-
sis, by comparing the frequency of disease in biologicaltions, with ever-larger numbers of genes contributing
and nonbiological relatives, that familial clustering hasever-smaller portions of the remaining variance (Pater-
a genetic basis (Ebers et al., 1995). The alternative strat-son, 1995).
egy is to embark on a genome scan, if large enoughIn the genetic analyses of murine autoimmunity re-
numbers of families with multiple affected cases areported to date, there is no significant evidence for heter-
available.ogeneity, and instead epistasis is inferred. It appears
In type 1 diabetes, two genome scans (over 250 mark-that the most likely mode of inheritance for autoimmune
ers) have been completed on 61 (Hashimoto et al., 1994)traits in mice, including EAE (Baker et al., 1995; Sundvall
and 96 (Davies et al., 1994) families with two or moreet al., 1995), type 1 diabetes (McAleer et al., 1995), and
siblings both affected by disease. If available, other af-SLE (Morel et al., 1994), is an epistatic one, with the
fected relatives can be used, as can pedigrees withfollowing characteristics: no single allele is sufficient or,
larger numbers of affected individuals in more than onein general, necessary to cause the disease; the more
generation, but affected sibling pairs are often the mostsusceptibility alleles at unlinked loci an individual has,
common and the most easily collected. The main con-the greater the risk of developing the disease; the risks
clusion was that the MHC-linked locus IDDM1 is proba-attributable to the main loci are roughly equal; combina-
bly the major locus and that a number of other genestions of genes cause the disease, but more than one
with lesser effects probably contribute to familial clus-combination may exist; and a significant component will
tering. This conclusion is remarkably, but not unexpect-probably remain unmapped owing to the existence of
edly, similar to that reached from genome scanning ofmany genes with weak effects.
the NOD mouse. Moreover, in line with the epidemiologi-
cal results from multiple sclerosis, it appears likely that
familial clustering could well be explained by the sharingMouse Congenic Strains
Not one of the mapped non-MHC susceptibility genes of susceptibility alleles at multiple loci (Todd, 1995).
For affected sibling pairs (or other relative pairs), thein Figure 1 has yet been identified. Owing to the reduced
penetrance of susceptibility alleles, fine mapping by contribution of a single locus to familial clustering can
be estimated from the linkage data (Risch, 1987), whichgenerating standard backcrosses or intercrosses is not
productive unless an extreme penetrant trait is available. in the case of type 1 diabetes was the distribution of
marker alleles in the affected sibling pairs. In familiesDefinitive fine mapping can beachieved by theconstruc-
tion of congenic strains in which specific chromosome from the United Kingdom, the ls value for MHC is about
2.4, much less than the overall ls value of 15, implyingsegments from the donor strain are introduced into the
genome of the recipient strain by repetitive backcross that more genes may be involved. Similar conclusions
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were reached for multiple sclerosis and celiac disease marker and the disease mutation, there will still be a
strong chance that the same marker alleles are associ-(Risch, 1987), and it is evident from Table 1 that the MHC
cannot fully account for familial clustering of rheumatoid ated with the susceptibility allele of the disease mutation
in present-day chromosomes. This is called linkage dis-arthritis, ankylosing spondylitis, ulcerative colitis, and
Crohn's disease. If the ls of the disease is large (greater equilibrium; alleles at marker loci more than 1 cM away
from the disease mutation will not tend to be associatedthan 6, for example) and the linkage of the MHC region
in families cannot account for it, then a genome scan with alleles of the disease mutation, because recombi-
nation with other chromosomes bearing different allelesis warranted.
In human type 1 diabetes, we expect epistasis be- at the microsatellite markers will have occurred fre-
quently enough to scramble the association of allelescause the risk to first, second, and third degree relatives
decreases more rapidly than would be expected for a such that they reach equilibrium and become randomly
associated. For example, if alleles at two linked markersheterogeneity model, in which risk would decrease in a
linear fashion by 50% from first to second and 50% each have a population frequency of 0.25, then the
chance of them occurring on the same chromosome isfrom second to third degree relatives (Rich, 1990; Risch,
1990). This is precisely analogous to the drastic reduc- 0.25 3 0.25 (0.06). However, if they are very close to
each other on the chromosome, they will tend to occurtion in NOD diabetes frequency from that observed in the
parental strain (90%) to that in the backcross progeny together on the same chromosome at a frequency
greater than 0.06.(13%). Preliminary studies suggest that the MHC IDDM1
locus on chromosome 6p21 and the insulin gene minisa- In regions of the genome that show some evidence
of linkage to disease detected in the genome scan,tellite locus IDDM2 on chromosome 11p15 interact epi-
statically (Cordell et al., 1995). therefore, testing markers every centimorgan should
yield a marker that shows linkage disequilibrium withIn genome scans, linkage results that have occurred
through random fluctuation are expected, referred to as disease. By characterizing new markers in the 1 cM
region flanking the first disease-associated marker, thefalse positives (Lander and Kruglyak, 1995; Risch, 1991).
They can be eliminated by testing additional, indepen- disease mutation can be located to regions smaller than
1 cM, orapproximately 106 bp of DNA, by finding markersdent data sets. The proportion of false-positive results
among true positives can be reduced by using large with alleles that show stronger and stronger association
with the disease. For the IDDM2 mutation this process,data sets, a map with denser markers, and multipoint
programs (Kruglyak and Lander, 1995; Weeks and called linkage disequilibrium mapping, reduced the
maximal chromosome region to only 4 3 103 bp of DNALathrop, 1995), which make the map even more informa-
tive, and by correcting for the testing of multiple genetic (Lucassen et al., 1993). This approach is very powerful
and much more sensitive than linkage analysis in fami-and clinical models (Risch, 1991).
Taking all the current mouse and human data to- lies. For example, the statistical support in all the com-
bined available type 1 diabetic families for linkage ofgether, environmental factors are probably not a major
cause of familial clustering (Ebers et al., 1995; Todd, IDDM2 is marginal (p 5 0.005 in 568 affected sibling
pair families; ls 5 1.3), but the evidence for linkage1995). This does not mean that environmental factors
are not important. They must be important in type 1 disequilibrium at IDDM2 is overwhelming (p 5 6.7 3
10214) (Bennett et al., 1996; Spielman et al., 1993). Cur-diabetes to explain seasonal and geographical varia-
tions in incidence, variations in disease frequency asso- rently, it is impractical and statistically problematical to
scan the whole human genome for linkage disequilib-ciated with emigration, and the dramatic increase in
disease incidence observed over the last 30 years. rium with 3000 markers, but in regions of linkage span-
ning 20 cM it is a feasible strategy. Already, there isHence, environmental factors exist but are probably
common and ubiquitous, affecting the general popula- evidence for the association of a microsatellite allele
with type 1 diabetes in a region of chromosome 2q thattion. We predict that individuals that carry susceptibility
alleles at most disease loci will probably be at high risk showed weak evidence of linkage in the genome scan
(Copeman et al., 1995). The history of the populationsof developing disease, in much the same way that the
selected strains of NOD and (NZB 3 NZW)F1 are studied and the age of the disease mutation relative to
uniquely susceptible to disease because they carry sus- the age of marker alleles are important factors (Jorde,
ceptible alleles at many loci. 1995). Linkage disequilibrium studies are best carried
out in families, but these families do not have to have
multiple affected children, but instead one affected childFine Mapping in Humans
Ironically, after genome scanning has been carried out, is sufficient (Copeman et al., 1995; Spielman et al., 1993;
Thomson, 1995). Families with one affected child arefine mapping and etiological mutation identification in
humans may proceed faster than in mice because hu- much more common than families with multiple cases
and are therefore much easier to collect.mans are outbred. Consider a disease mutation that
arose on a human chromosome 2000 years ago. It will Until recently the candidate gene approach domi-
nated the genetic analysis of autoimmunity. Candidatebe flanked by microsatellite markers with certain alleles,
and hence if those microsatellites could be typed, their genes are, however, numerous, and aside from the MHC
in several diseases and the insulin gene in type 1 diabe-alleles would give a specific and recognizable signature
to the chromosome region containing the disease muta- tes, associations of many candidate genes have been
reported but not confirmed. Nevertheless, candidatetion. If a marker is very close, within 1 cM (Jorde, 1995),
to a disease mutation, then despite 2000 years of oppor- genes in regions of linkage, or better still in regions of
linkage disequilibrium, do warrant some priority.tunities for recombination during meiosis between the
Cell
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